SUMO1
Reactivité: Humain
WB, ELISA, IHC, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
1. Western blotting: 1/1,000 2. Immunofluorescence staining: 1/100 dilution 3. Immunohistochemistry,Frozen section: 1/100 dilution 4. ELISA (assay dependent) Other applications have not been tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS (x1), 50 % glycerol. Azide and carrier free.
Agent conservateur
Azide free
Stock
-20 °C
Stockage commentaire
Upon arrival centrifuge briefly and store at -20 C.
Ulrich: "The fast-growing business of SUMO chains." dans: Molecular cell, Vol. 32, Issue 3, pp. 301-5, (2008) (PubMed).
Saitoh, Uchimura, Tachibana, Sugahara, Saitoh, Nakao: "In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies." dans: Experimental cell research, Vol. 312, Issue 8, pp. 1418-30, (2006) (PubMed).
Uchimura, Ichimura, Uwada, Tachibana, Sugahara, Nakao, Saitoh: "Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation." dans: The Journal of biological chemistry, Vol. 281, Issue 32, pp. 23180-90, (2006) (PubMed).
Cheng, Bawa, Lee, Gong, Yeh: "Role of desumoylation in the development of prostate cancer." dans: Neoplasia (New York, N.Y.), Vol. 8, Issue 8, pp. 667-76, (2006) (PubMed).
Antigène
SUMO1
(Small Ubiquitin Related Modifier Protein 1 (SUMO1))
SUMO (Small Ubiquitin-like Modifier) proteins are a family of small proteins that are covalently attached to and detached from other proteins in cells to modify their function. Unlike ubiquitination, which targets proteins for degradation, SUMO modification plays a critical role in a number of cellular functions including nucleocytoplasmic transport, gene expression, cell cycle and formation of subnuclear structures such as promyelocytic leukemia (PML) bodies. There are three confirmed SUMO isoforms in human, SUMO1, SUMO2 and SUMO3. SUMO2 /3 show a high degree of similarity to each other and are distinct from SUMO1. Individual SUMO family members are all targeted to different proteins with diverse biological functions. SUMO-1 is conjugated to RanGAP, PML, p53 and IkappaB-alpha to regulate nuclear trafficking, formation of subnuclear structures, regulation of transcriptional activity and protein stability. SUMO1 is encoded as a 101 aa protein and first Met and C-terminal 4 aa are removed from the preprotein.